Increase of urokinase-type plasminogen activator receptor expression in human gingival fibroblasts by Porphyromonas gingivalis lipopolysaccharide

被引:14
作者
Ogura, N
Nagura, H
Abiko, Y
机构
[1] Nihon Univ, Sch Dent, Dept Oral Surg, Matsudo, Chiba 271, Japan
[2] Nihon Univ, Sch Dent, Dept Biochem, Matsudo, Chiba 271, Japan
关键词
fibroblasts; extracellular matrix; lipopolysaccharides; urokinase;
D O I
10.1902/jop.1999.70.4.402
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Urokinase-type plasminogen activator receptor (uPAR) presenting on the cell surface with glycosylphosphatidylinositol (GPI) anchor is a key component in the plasminogen activator (PA)-plasmin system and plays a critical role in extracellular matrix degradation. It is believed that uPAR serves to localize and accelerate this generation system. In this study, we examined the levels of both uPA and uPAR in human gingival fibroblasts treated with Porphyromonas gingivalis lipopolysaccharide (LPS). Methods: Human gingival fibroblasts from the seventh to tenth doubling passages were plated at 5 x 10(4) cells per well in 24-well plates. The confluent-stage cells were cultured for 24 hours in alpha-MEM medium containing 2% fetal calf serum, after which they were incubated with P. gingivalis LPS. PA activity was measured using plasminogen and plasmin substrate S2251. Results: PA activity in the cell lysate was increased by LPS and reached maximum at 1 mu g/ml LPS after being incubated for 8 hours. PA activity released by phosphatidylinositol-specific phospholipase C, which detaches the GPI anchor, was also increased by LPS. The activity was inhibited by amiloride, which is a specific inhibitor for uPA. LPS increased the protein and mRNA levels of both uPA and uPAR in gingival fibroblasts. Conclusions: These findings suggest that increase of the uPAR level by LPS may play an important role in the progression of periodontal diseases through pericellular proteolysis.
引用
收藏
页码:402 / 408
页数:7
相关论文
共 41 条
[1]  
BARNATHAN ES, 1990, J BIOL CHEM, V265, P2865
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]  
BROWN JM, 1995, ARCH ORAL BIOL, V40, P839, DOI 10.1016/0003-9969(95)00049-U
[4]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[5]  
DEVRIES C, 1988, BIOCHEM, V27, P2526
[6]   INTERACTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) WITH ITS CELLULAR RECEPTOR (U-PAR) INDUCES PHOSPHORYLATION ON TYROSINE OF A 38 KDA PROTEIN [J].
DUMLER, I ;
PETRI, T ;
SCHLEUNING, WD .
FEBS LETTERS, 1993, 322 (01) :37-40
[7]  
ELLIS V, 1991, J BIOL CHEM, V266, P12752
[8]  
ELLIS V, 1989, J BIOL CHEM, V264, P2185
[9]   THE UROKINASE RECEPTOR IS REQUIRED FOR HUMAN MONOCYTE CHEMOTAXIS IN-VITRO [J].
GYETKO, MR ;
TODD, RF ;
WILKINSON, CC ;
SITRIN, RG .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (04) :1380-1387
[10]   FIBRINOLYTIC-ACTIVITY IN PERIODONTAL-DISEASE - THE RELATIONSHIP BETWEEN FIBRINOLYTIC-ACTIVITY AND SEVERITY OF PERIODONTAL-DISEASE [J].
HIDAKA, N ;
MAEDA, K ;
KAWAKAMI, C ;
AONO, M ;
OKADA, H .
JOURNAL OF PERIODONTOLOGY, 1981, 52 (04) :181-186